Rapid GMP-Compliant Expansion of SARS-CoV-2–Specific T Cells From Convalescent Donors for Use as an Allogeneic Cell Therapy for COVID-19

Overview of attention for article published in Frontiers in immunology, January 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

blogs: 1 blog
twitter: 2 X users

patent: 2 patents

Citations

dimensions_citation: 27 Dimensions

Readers on

mendeley: 66 Mendeley

Summary Blogs X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

TERMINAL EFFECTOR T CELLS, METHOD FOR PRODUCING AND ISOLATING SAME AND THERAPEUTIC USE…

Application WO-2023066992-A1

World Intellectual Property Organisation (WIPO)

TERMINAL EFFECTIVE T CELLS, METHOD FOR THEIR PRODUCTION AND THEIR ISOLATION AND THEIR…

Application FR-3128229-A1

France

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.